Annual report pursuant to Section 13 and 15(d)

Business, Presentation and Recent Accounting Pronouncements (Details)

v3.23.1
Business, Presentation and Recent Accounting Pronouncements (Details)
12 Months Ended
Nov. 22, 2022
USD ($)
Sep. 27, 2022
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Sep. 26, 2022
shares
Subsidiary, Sale of Stock [Line Items]          
Cash and cash equivalents     $ 5,964,556 $ 7,854,690  
Accumulated deficit     (134,462,959) (120,879,349)  
Proceeds from warrant inducements $ 2,700,000   2,738,831 $ 0  
Warrant inducement, placement agent fees 300,000        
Warrant inducement expense $ 100,000   $ 381,360    
Reverse stock split, conversion ratio   0.025      
Common stock, authorized (in shares) | shares   50,000,000 50,000,000 50,000,000  
Reverse stock split, number of fractional shares issued (in shares) | shares   0      
Common stock, outstanding (in shares) | shares   1,079,045 1,796,472 316,599 43,163,123